| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.051 | 0.4 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |